rs61747430

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_016507.4(CDK12):​c.3391A>G​(p.Ile1131Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00162 in 1,614,184 control chromosomes in the GnomAD database, including 37 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I1131N) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0088 ( 19 hom., cov: 32)
Exomes 𝑓: 0.00087 ( 18 hom. )

Consequence

CDK12
NM_016507.4 missense

Scores

2
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3O:1

Conservation

PhyloP100: 1.07

Publications

3 publications found
Variant links:
Genes affected
CDK12 (HGNC:24224): (cyclin dependent kinase 12) Enables RNA polymerase II CTD heptapeptide repeat kinase activity and cyclin binding activity. Involved in phosphorylation of RNA polymerase II C-terminal domain; protein autophosphorylation; and regulation of MAP kinase activity. Located in nuclear speck. Part of cyclin K-CDK12 complex. [provided by Alliance of Genome Resources, Apr 2022]
CDK12 Gene-Disease associations (from GenCC):
  • Tourette syndrome
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_016507.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0022045374).
BP6
Variant 17-39525947-A-G is Benign according to our data. Variant chr17-39525947-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 133857.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00882 (1344/152296) while in subpopulation AFR AF = 0.0306 (1273/41560). AF 95% confidence interval is 0.0292. There are 19 homozygotes in GnomAd4. There are 628 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 19 Unknown gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_016507.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDK12
NM_016507.4
MANE Select
c.3391A>Gp.Ile1131Val
missense
Exon 13 of 14NP_057591.2Q9NYV4-1
CDK12
NM_015083.4
c.3391A>Gp.Ile1131Val
missense
Exon 13 of 14NP_055898.1Q9NYV4-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDK12
ENST00000447079.6
TSL:1 MANE Select
c.3391A>Gp.Ile1131Val
missense
Exon 13 of 14ENSP00000398880.4Q9NYV4-1
CDK12
ENST00000430627.6
TSL:1
c.3391A>Gp.Ile1131Val
missense
Exon 13 of 14ENSP00000407720.2Q9NYV4-2
CDK12
ENST00000922307.1
c.3313A>Gp.Ile1105Val
missense
Exon 12 of 13ENSP00000592366.1

Frequencies

GnomAD3 genomes
AF:
0.00883
AC:
1344
AN:
152178
Hom.:
19
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0307
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00373
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00431
GnomAD2 exomes
AF:
0.00241
AC:
605
AN:
251406
AF XY:
0.00167
show subpopulations
Gnomad AFR exome
AF:
0.0335
Gnomad AMR exome
AF:
0.00147
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000440
Gnomad OTH exome
AF:
0.000489
GnomAD4 exome
AF:
0.000866
AC:
1266
AN:
1461888
Hom.:
18
Cov.:
32
AF XY:
0.000708
AC XY:
515
AN XY:
727244
show subpopulations
African (AFR)
AF:
0.0312
AC:
1043
AN:
33478
American (AMR)
AF:
0.00179
AC:
80
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53418
Middle Eastern (MID)
AF:
0.000520
AC:
3
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000261
AC:
29
AN:
1112010
Other (OTH)
AF:
0.00179
AC:
108
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
70
141
211
282
352
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00882
AC:
1344
AN:
152296
Hom.:
19
Cov.:
32
AF XY:
0.00843
AC XY:
628
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.0306
AC:
1273
AN:
41560
American (AMR)
AF:
0.00373
AC:
57
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000735
AC:
5
AN:
68030
Other (OTH)
AF:
0.00426
AC:
9
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
63
126
188
251
314
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00655
Hom.:
7
Bravo
AF:
0.0107
Asia WGS
AF:
0.00260
AC:
9
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.000178

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
CDK12-related disorder (1)
-
-
1
Hereditary breast ovarian cancer syndrome (1)
-
-
1
not provided (1)
-
-
-
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.078
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
16
DANN
Benign
0.73
DEOGEN2
Benign
0.0083
T
Eigen
Benign
-0.74
Eigen_PC
Benign
-0.52
FATHMM_MKL
Uncertain
0.83
D
LIST_S2
Benign
0.77
T
MetaRNN
Benign
0.0022
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-0.16
N
PhyloP100
1.1
PrimateAI
Uncertain
0.55
T
PROVEAN
Benign
-0.010
N
REVEL
Benign
0.13
Sift
Benign
0.21
T
Sift4G
Benign
1.0
T
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.015
gMVP
0.13
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs61747430;
hg19: chr17-37682200;
COSMIC: COSV104713587;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.